Duration Of Folfox Adjuvant Chemotherapy In High-Risk Stage Ii And Stage Iii Colon Cancer With Deficient Dna Mismatch Repair.

Zehua Wu,Huabin Hu,Chao Wang,Yan Huang,Yanhong Deng

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 3|浏览6

暂无评分

摘要

4075Background: In the IDEA collaboration, noninferiority was not confirmed for 3 months versus 6 months of FOLFOX adjuvant chemotherapy among patients with high-risk stage II and stage III colon c...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要